Cholesterol

apolipoprotein B ; Homo sapiens







723 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32185503 Microbiome and Cardiovascular Disease. 2022 1
2 34773457 Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk: The Debate Is Over. 2022 Mar 1 1
3 35049039 Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. 2022 Mar 1
4 35283414 Comparison of Lipoprotein Cholesterol Levels in Golden Syrian Hamster Administrated trans-Octadecenoic Acid Positional Isomers. 2022 Apr 1 1
5 35294778 Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments? 2022 Jul 3
6 35320320 Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia). 2022 1
7 35533992 Hyperreflective material serves as a potential biomarker of dyslipidemia in diabetic macular edema. 2022 May 6 1
8 35567295 Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China. 2022 May 14 1
9 35589500 Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects. 2022 May 8 4
10 31656126 Riboflavin deficiency alters cholesterol homeostasis partly by reducing apolipoprotein B100 synthesis in HepG2 cells. 2021 Jun 1
11 33189625 Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm. 2021 Jan-Feb 1
12 33229928 Apolipoprotein B: the Rosetta Stone of lipidology. 2021 Apr 1 3
13 33413638 DNA methylation and lipid metabolism: an EWAS of 226 metabolic measures. 2021 Jan 7 1
14 33461915 Elevated Apolipoprotein B/A-1 Ratio is Associated With an Increased Risk of Aortic Stenosis: Experience From the AMORIS Cohort. 2021 Jul 1
15 33598387 A Comparison of Lipids and apoB in Asian Indians and Americans. 2021 Jan 20 3
16 33626337 Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease. 2021 Mar 4 1
17 33671529 Common Genetic Variations Involved in the Inter-Individual Variability of Circulating Cholesterol Concentrations in Response to Diets: A Narrative Review of Recent Evidence. 2021 Feb 22 1
18 33736827 Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. 2021 Mar 23 3
19 33770136 Correction: Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations. 2021 1
20 33862237 Biological anti-psoriatic therapy profoundly affects high-density lipoprotein function. 2021 Jul 1
21 33870931 Update on apolipoprotein B. 2021 Aug 1 2
22 33941192 Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON. 2021 Apr 30 2
23 34024685 Second-trimester maternal lipid profiles rather than glucose levels predict the occurrence of neonatal macrosomia regardless of glucose tolerance status: A matched cohort study in Beijing. 2021 Aug 2
24 34121862 Prevalence of ApoB100 rs693 gene polymorphism in metabolic syndrome among female students at King Abdulaziz University. 2021 Jun 1
25 34138676 Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes? 2021 Nov 2
26 34156559 ApoB gene polymorphism (rs676210) and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease. 2021 Jun 22 1
27 34258898 Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood. 2021 Jun 30 1
28 34292395 Association of serum apolipoprotein B with retinal neurovascular structural alterations in patients with type 2 diabetes: an optical coherence tomography angiography study. 2021 Dec 1
29 34298557 Next-generation sequencing to confirm clinical familial hypercholesterolemia. 2021 Jul 23 1
30 34305563 Bioinformatic Analysis of the Proteome in Exosomes Derived From Plasma: Exosomes Involved in Cholesterol Metabolism Process of Patients With Spinal Cord Injury in the Acute Phase. 2021 2
31 34441341 Cholesterol Efflux Capacity Associates with the Ankle-Brachial Index but Not All-Cause Mortality in Patients with Peripheral Artery Disease. 2021 Aug 4 2
32 34616421 Single Nucleotide Polymorphisms in Apolipoprotein B, Apolipoprotein E, and Methylenetetrahydrofolate Reductase Are Associated With Serum Lipid Levels in Northern Chilean Subjects. A Pilot Study. 2021 1
33 34656950 Postprandial dyslipidemia after a standardized high-fat meal in BMI-matched healthy individuals, and in subjects with prediabetes or type 2 diabetes. 2021 Nov 1
34 34677405 Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. 2021 Oct 8 1
35 34680453 The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage Cholesterol Efflux-But Not Gut Microbial-Derived Metabolites-Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction. 2021 Sep 27 3
36 34706556 LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease. 2021 Dec 2
37 34729547 Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives. 2021 Jun 1
38 34808137 AICAR upregulates ABCA1/ABCG1 expression in the retinal pigment epithelium and reduces Bruch's membrane lipid deposit in ApoE deficient mice. 2021 Dec 2
39 34840125 Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA). 2021 Dec 1
40 34845932 Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts. 2021 Dec 7 1
41 34939807 Dynamics of Apolipoprotein B-100 in Interaction with Detergent Probed by Incoherent Neutron Scattering. 2021 Dec 30 2
42 35069437 The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome. 2021 1
43 31831577 Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD. 2020 Jan 7 2
44 31928713 Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. 2020 Feb 1
45 32039990 Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. 2020 Apr 1
46 32082368 Genome-Wide DNA Methylation Patterns in Persistent Attention-Deficit/Hyperactivity Disorder and in Association With Impulsive and Callous Traits. 2020 1
47 32084179 Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations. 2020 2
48 32127339 Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study. 2020 May 7 1
49 32159456 Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic Risk. 2020 May 1
50 32203549 Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. 2020 Mar 1